OasisLMS

Glomerular medicine is exploding with exciting new understanding of disease pathogenesis, which has led to developments in novel genetic and serological diagnostic tools, clinical trials, and potential new treatments. In this program, a panel of experts discusses these advances in the form of comprehensive updates and case-based discussions (adult and pediatric) with time for audience questions.

This program explores novel changes in our favorites: IgA nephropathy, lupus nephritis, podocytopathies (FSGS/minimal change disease [MCD]), ANCA-associated vasculitis, membranous glomerulonephritis, complement in kidney disease, and monoclonal gammopathies of renal significance. Hot topics are also addressed, including how and when to use genetics in the diagnosis and treatment of glomerular diseases, type IV collagen-related diseases, and anticipated uses of artificial intelligence (AI) in the diagnosis of glomerular diseases. Participants learn about cutting-edge clinical applications in treatment, pathology, and genetics that continue to change the diagnostic and therapeutic landscape in glomerular medicine.

Learning Objectives
Upon completion of the program, the participant will be able to:

• Describe and integrate pathophysiology, pathology, diagnostics, and therapeutic options for glomerular diseases
• Summarize information from current basic and clinical research studies and its application to the diagnosis and management of glomerular diseases
• Analyze nuances in the treatment of patients with difficult-to-manage glomerular diseases
• Discuss when to use novel medications and/or to enroll patients in clinical trials as medical therapy options

Target Audience

• Physicians
• Researchers
• Medical and Other Trainees
• Nurses and Nurse Practitioners
• Pharmacists
• Physician Assistants
• Other Healthcare Professionals

Commercial Support
Support for this Early Program is provided by an educational grant from Vera Therapeutics, Inc.

Privacy Policy/Confidentiality
http://www.asn-online.org/terms/privacy.aspx    
    
ASN Medical Disclaimer     
http://www.asn-online.org/terms/medical-disclaimer.aspx

Please note that only learners who participated in this Early Program in-person in Houston can claim credits.

Accreditation Statement

In support of improving patient care, the American Society of Nephrology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

AMA Credit Designation Statement – Physicians:
The American Society of Nephrology designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NCCPA Credit Designation Statement – Physician Assistants:
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society.
Physician Assistants may receive a Certificate of Participation that states this activity has been approved for up to 8.25 AMA PRA Category 1 Credits™.

CME/CPE Deadline Date: December 17, 2025 at 11:59 PM ET
Estimated Time for Completion: 8.25 hours

Method of Participation

1. Participate in the Early Program (verification required).
2. In the activity, click the Questionnaire tab, and complete the Demographics Questionnaire.
3. Complete the General Evaluation.
4. Select the Claim Credit tab. Use the Credit Selection dropdown to select your applicable credit type. If none apply, select None of the Above - Print Participation Certificate.
   1. If a CE credit type is selected:
      1. The number of credits defaults to the maximum amount. Adjust based on your actual participation. 
      2. Select the Claim button.
      3. Select the View Certificate button. It may take up to 15 minutes for your certificate to show.
   2. If None of the Above - Print Participation Certificate is selected:
      1. Select I understand the above - continue to participation certificate.
      2. Select Get Certificate.

Co-Chair(s)

• Rupali S. Avasare, MD
• John Cijiang He, MD, PhD, FASN

A full faculty listing is available here. 

ASN Disclosure Policy
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ASN requires all individuals in a position to control content for Kidney Week Early Programs to disclose all financial relationships with ineligible companies.

All disclosed financial relationships were reviewed by ASN. Any relevant financial relationships with ineligible companies were identified and mitigated prior to the activity.

View the ASN Disclosure Policy here.

• Broadband cable, DSL, or high-speed internet connection
• Please use the latest version of Google Chrome for the best viewing experience. Mozilla and Safari can also be used; however, Microsoft Edge is not recommended. Please check the ASN auto-detect settings page.
• 533 MHz or faster processor
• 512 MB RAM or higher
• Adobe Reader (free download)
• Computer which can play MP3 files
• Apple iPad/iPhone running HTML5
• Android devices